These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 34000327

  • 1. Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses.
    Hollmann A, Cardoso NP, Espeche JC, Maffía PC.
    Peptides; 2021 Aug; 142():170570. PubMed ID: 34000327
    [Abstract] [Full Text] [Related]

  • 2. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery.
    Essa RZ, Wu YS, Batumalaie K, Sekar M, Poh CL.
    Pharmacol Rep; 2022 Dec; 74(6):1166-1181. PubMed ID: 36401119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR, Guha S, Wu E, Ghimire J, Wang Y, He J, Garry RF, Wimley WC.
    J Virol; 2020 Nov 09; 94(23):. PubMed ID: 32907984
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nuclear trafficking of proteins from RNA viruses: potential target for antivirals?
    Caly L, Wagstaff KM, Jans DA.
    Antiviral Res; 2012 Sep 09; 95(3):202-6. PubMed ID: 22750233
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
    Obajuluwa AO, Okiki PA, Obajuluwa TM, Afolabi OB.
    Pan Afr Med J; 2020 Sep 09; 37():285. PubMed ID: 33654512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Non-infectious plasmid engineered to simulate multiple viral threat agents.
    Carrera M, Sagripanti JL.
    J Virol Methods; 2009 Jul 09; 159(1):29-33. PubMed ID: 19442841
    [Abstract] [Full Text] [Related]

  • 19. Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus.
    Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E.
    PLoS Pathog; 2014 May 09; 10(5):e1004166. PubMed ID: 24874215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.